The Amyloidosis Channel is supported with funding from Prothena (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ISA 2022 | Closing the gap between basic and clinical research in AL and ATTR amyloidosis
Marina Ramirez-Alvarado
• 7 Sep 2022
Marina Ramirez-Alvarado, PhD, Mayo Clinic, Rochester, MN, comments on the importance of encouraging collaboration between different stakeholders in the field of amyloidosis to close the gap between basic and clinical research in AL and ATTR amyloidosis. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.
Disclosures
Honorarium from Attralus
